Skip to content

Form 4 filed by Kieser Brian Joseph

Kieser Brian Joseph filed this Form 4 on NXGL (NEXGEL, INC.) with 10 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-14 02:59:13 UTC.

Accession
0001493152-26-051920
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: NXGL · NEXGEL, INC. (CIK 1468929)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-11-10P bought+133,216$5.5133,216I By Sequence LifeScience, Inc.
Warrant to Purchase Common Stock (the "PIPE Warrant") derivative2026-11-10P bought+133,216$0133,216I By Sequence LifeScience, Inc.
Convertible Promissory Note (before amendment) derivative2026-11-10D returned to the issuer+83,3340D
Convertible Promissory Note (as amended) derivative2026-11-10A granted+181,819181,819D
Warrant to Purchase Common Stock derivative2026-11-10D returned to the issuer+41,6670D
Existing Warrant (as amended) derivative2026-11-10A granted+41,66741,667D
Convertible Promissory Note (before amendment) derivative2026-11-10D returned to the issuer+458,3340I By Sequence LifeScience, Inc.
Convertible Promissory Note (as amended) derivative2026-11-10A granted+1,000,0001,000,000I By Sequence LifeScience, Inc.
Existing Warrant (before amendment) derivative2026-11-10D returned to the issuer+229,1670I By Sequence LifeScience, Inc.
Existing Warrant (as amended) derivative2026-11-10A granted+229,167229,167I By Sequence LifeScience, Inc.